Author:
Chan Austin,Patel Keyur,Naggie Susanna
Publisher
Springer Science and Business Media LLC
Reference104 articles.
1. WHO. Hepatitis C fact sheet. Geneva: WHO; 2016. Available at: http://www.who.int/mediacentre/factsheets/fs164/en/ . Accessed 29 Aug 2016.
2. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333–42.
3. Bochud PY, Cai T, Overbeck K, Bochud M, Dufour JF, Mullhaupt B, et al. Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. J Hepatol. 2009;51(4):655–66.
4. Kattakuzhy S, Levy R, Rosenthal E, Tang L, Wilson E, Kottilil S. Hepatitis C genotype 3 disease. Hepatol Int. 2016;10(6):861–70.
5. Bristol-Myers Squibb Company DAKLINZA (daclatasvir) [Package insert]. Princeton, NJ. http://packageinserts.bms.com/pi/pi_daklinza.pdf . (Revised February 2016).
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献